-
Designing the Messenger: Story of the mRNA Vaccine
Neeta Ratanghayra
November 05, 2020
In early January this year, Chinese authorities shared the genetic sequence of SARS-CoV-2, the novel coronavirus.
-
How AI is Redefining the Pharmaceutical Industry in China
Neeta Ratanghayra
October 22, 2020
Artificial intelligence (AI) refers to the use of automated algorithms to perform the tasks conventionally done with human intelligence.
-
Animal Studies for Predicting Drug Toxicity - Is it Time to Re-Evaluate the Benefits?
Neeta Ratanghayra
September 02, 2020
The use of animal testing has significant benefits in medical research; however, increased costs, extremely high failure rates, and delays in drug approval have led many to re-evaluate its value in drug development.
-
Monoclonal Antibodies - The Challenges in Drug Development
Neeta Ratanghayra
July 28, 2020
Monoclonal antibodies (mAb) are approved in a wide range of conditions and represent the largest class of biotherapeutic products. mAbs are large molecules with complex structures and functions.
-
Phenotypic Screening and Target-Based Drug Discovery: Is it Time to Unite?
Neeta Ratanghayra
May 27, 2020
With advancements in biomedical science, drug discovery has evolved different strategies. However, with this dramatic progress, concerns have emerged regarding the efficiency of translating these technical advances into safe and efficacious new drugs.
-
NASH: Seizing Opportunities in the Untapped Market
Neeta Ratanghayra
April 23, 2020
Nonalcholic steatohepatitis (NASH) is a hard to diagnose liver disease, characterized by steatosis, chronic inflammation, and progressive fibrosis that may lead to cirrhosis, liver failure. NASH is also a significant risk factor for the development of hep
-
Conducting Clinical Trials amid the COVID-19 Outbreak: FDA Encourages Sponsors to Go Virtual
Neeta Ratanghayra
April 08, 2020
For pharmaceutical companies, one of the most significant operational impacts of the COVID-19 is on clinical trials. On March 19, 2020, the U.S. Food and Drug Administration (FDA) issued guidance on the conduct of clinical trials during the COVID-19 pande
-
Pharma and Biotech Review: Treatment Options for COVID-19: Decoding the Latest Developments
Neeta Ratanghayra
March 11, 2020
The Coronavirus Disease 2019 (COVID-19), which emerged in Wuhan, a city of 11 million in Hubei province, has spread to more than two dozen countries, taking the lives of more than 2,800 people.
-
The Next Horizon of Innovations in Drug Delivery
Neeta Ratanghayra
February 17, 2020
The rise of biopharmaceuticals and the growing interest towards patient-centricity has paved the way for some fascinating innovations in drug delivery.
-
Recent Innovations in the Field Of Drug Delivery
Neeta Ratanghayra
December 23, 2019
With innovators exploring new approaches to deliver drugs, the arena for drug delivery technologies continues to expand. In this article we look at some innovative drug delivery technologies which are at various phases of development.